7 Analysts Have This to Say About Guardant Health
Portfolio Pulse from Benzinga Insights
Guardant Health (NASDAQ:GH) received 7 analyst ratings in the last quarter, with 3 bullish, 4 somewhat bullish, and none bearish. The average price target is $41.57, representing an upside from the current price of $22.2. This target is a 20.44% decrease from the previous target of $52.25. Analysts rate stocks based on detailed research and provide guidance on performance metrics.

November 13, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health has a positive outlook from analysts with 7 ratings skewing towards bullish. The average price target suggests a substantial upside potential from the current market price.
The unanimous bullish and somewhat bullish ratings from analysts indicate a strong positive sentiment towards Guardant Health. The average price target being nearly double the current stock price suggests that analysts expect significant growth, which could influence investor perception and drive short-term price movement upwards. However, the decrease in the average price target from the previous quarter indicates some caution, which is why the importance is not at the maximum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100